{"id":912108,"date":"2025-11-20T08:30:20","date_gmt":"2025-11-20T13:30:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/"},"modified":"2025-11-20T08:30:20","modified_gmt":"2025-11-20T13:30:20","slug":"ptc-therapeutics-to-host-rd-day","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/","title":{"rendered":"PTC Therapeutics to Host R&amp;D Day"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">\n        <i>Event to take place on <span class=\"xn-chron\">Dec. 2, 2025<\/span> in <span class=\"xn-location\">New York City<\/span><\/i>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">WARREN, N.J.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Nov. 20, 2025<\/span><\/span> \/PRNewswire\/ &#8212; PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host an R&amp;D Day to discuss its pipeline on Dec.\u00a02, 2025, at <span class=\"xn-chron\">9:30 a.m. EST<\/span> in <span class=\"xn-location\">New York City<\/span>. The event will also be webcast.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2582388\/PTC_LOGO_Logo_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2582388\/PTC_LOGO_Logo_Logo.jpg\" title=\"PTC Therapeutics, Inc. Logo (PRNewsfoto\/PTC Therapeutics, Inc.)\" alt=\"PTC Therapeutics, Inc. Logo (PRNewsfoto\/PTC Therapeutics, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <span class=\"xn-person\">Matthew B. Klein<\/span>, M.D., Chief Executive Officer, and PTC research and development team leaders will provide an update on the company&#8217;s proprietary small molecule splicing and inflammation platforms, including new targets and programs.<\/p>\n<p>To register for the webcast, please visit the Events and Presentations page on the Investors section of the PTC Therapeutics website at <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4563144-1&amp;h=1475172351&amp;u=http%3A%2F%2Fir.ptcbio.com%2Fevents-presentations&amp;a=http%3A%2F%2Fir.ptcbio.com%2Fevents-presentations\" target=\"_blank\" rel=\"nofollow\">http:\/\/ir.ptcbio.com\/events-presentations<\/a>. A replay will be available for approximately 30 days following the event.<\/p>\n<p>\n        <b>ABOUT PTC THERAPEUTICS, INC.<br \/><\/b>PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company&#8217;s strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4563144-1&amp;h=4156364047&amp;u=http%3A%2F%2Fwww.ptcbio.com%2F&amp;a=www.ptcbio.com\" target=\"_blank\" rel=\"nofollow\">www.ptcbio.com<\/a> and follow us on LinkedIn, X, Facebook and Instagram.<\/p>\n<p>\n        <b>For More Information: <\/b>\n      <\/p>\n<p>\n        <b>Investors:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Ellen Cavaleri<\/span><br \/>\n        <br \/>+1 (615) 618-6228<br \/><a href=\"mailto:ecavaleri@ptcbio.com\" target=\"_blank\" rel=\"nofollow\">ecavaleri@ptcbio.com<\/a>\u00a0<\/p>\n<p>\n        <b>Media:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Jeanine Clemente<\/span><br \/>\n        <br \/>+1 (908) 912-9406<br \/><a href=\"mailto:jclemente@ptcbio.com\" target=\"_blank\" rel=\"nofollow\">jclemente@ptcbio.com<\/a>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=NY29466&amp;sd=2025-11-20\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/ptc-therapeutics-to-host-rd-day-302621284.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/ptc-therapeutics-to-host-rd-day-302621284.html<\/a><\/p>\n<p>SOURCE  PTC Therapeutics, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY29466&amp;Transmission_Id=202511200800PR_NEWS_USPR_____NY29466&amp;DateId=20251120\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Event to take place on Dec. 2, 2025 in New York City WARREN, N.J. , Nov. 20, 2025 \/PRNewswire\/ &#8212; PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host an R&amp;D Day to discuss its pipeline on Dec.\u00a02, 2025, at 9:30 a.m. EST in New York City. The event will also be webcast. Matthew B. Klein, M.D., Chief Executive Officer, and PTC research and development team leaders will provide an update on the company&#8217;s proprietary small molecule splicing and inflammation platforms, including new targets and programs. To register for the webcast, please visit the Events and Presentations page on the Investors section of the PTC Therapeutics website at http:\/\/ir.ptcbio.com\/events-presentations. A replay will be available for approximately &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PTC Therapeutics to Host R&amp;D Day&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-912108","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PTC Therapeutics to Host R&amp;D Day - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PTC Therapeutics to Host R&amp;D Day - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Event to take place on Dec. 2, 2025 in New York City WARREN, N.J. , Nov. 20, 2025 \/PRNewswire\/ &#8212; PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host an R&amp;D Day to discuss its pipeline on Dec.\u00a02, 2025, at 9:30 a.m. EST in New York City. The event will also be webcast. Matthew B. Klein, M.D., Chief Executive Officer, and PTC research and development team leaders will provide an update on the company&#8217;s proprietary small molecule splicing and inflammation platforms, including new targets and programs. To register for the webcast, please visit the Events and Presentations page on the Investors section of the PTC Therapeutics website at http:\/\/ir.ptcbio.com\/events-presentations. A replay will be available for approximately &hellip; Continue reading &quot;PTC Therapeutics to Host R&amp;D Day&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-20T13:30:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2582388\/PTC_LOGO_Logo_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PTC Therapeutics to Host R&amp;D Day\",\"datePublished\":\"2025-11-20T13:30:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/\"},\"wordCount\":265,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2582388\\\/PTC_LOGO_Logo_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/\",\"name\":\"PTC Therapeutics to Host R&amp;D Day - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2582388\\\/PTC_LOGO_Logo_Logo.jpg\",\"datePublished\":\"2025-11-20T13:30:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2582388\\\/PTC_LOGO_Logo_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2582388\\\/PTC_LOGO_Logo_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ptc-therapeutics-to-host-rd-day\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PTC Therapeutics to Host R&amp;D Day\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PTC Therapeutics to Host R&amp;D Day - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/","og_locale":"en_US","og_type":"article","og_title":"PTC Therapeutics to Host R&amp;D Day - Market Newsdesk","og_description":"PR Newswire Event to take place on Dec. 2, 2025 in New York City WARREN, N.J. , Nov. 20, 2025 \/PRNewswire\/ &#8212; PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host an R&amp;D Day to discuss its pipeline on Dec.\u00a02, 2025, at 9:30 a.m. EST in New York City. The event will also be webcast. Matthew B. Klein, M.D., Chief Executive Officer, and PTC research and development team leaders will provide an update on the company&#8217;s proprietary small molecule splicing and inflammation platforms, including new targets and programs. To register for the webcast, please visit the Events and Presentations page on the Investors section of the PTC Therapeutics website at http:\/\/ir.ptcbio.com\/events-presentations. A replay will be available for approximately &hellip; Continue reading \"PTC Therapeutics to Host R&amp;D Day\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-20T13:30:20+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2582388\/PTC_LOGO_Logo_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PTC Therapeutics to Host R&amp;D Day","datePublished":"2025-11-20T13:30:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/"},"wordCount":265,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2582388\/PTC_LOGO_Logo_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/","name":"PTC Therapeutics to Host R&amp;D Day - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2582388\/PTC_LOGO_Logo_Logo.jpg","datePublished":"2025-11-20T13:30:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2582388\/PTC_LOGO_Logo_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2582388\/PTC_LOGO_Logo_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ptc-therapeutics-to-host-rd-day\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PTC Therapeutics to Host R&amp;D Day"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/912108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=912108"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/912108\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=912108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=912108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=912108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}